Oncology and Hematology

Oncology and Hematology Clinical Practice

Stay current with Oncology and Hematology education that fits how you practice. ReachMD offers practical, on-demand clinical content for oncologists, hematologists, oncology nurses, pharmacists, fellows, APPs, and the full cancer care team. Explore expert discussions, case-based programs, CME/CE opportunities, industry features, and news across solid tumors, hematologic malignancies, biomarker-driven care, immunotherapy, targeted therapy, supportive care, and more.

Use this page to find relevant oncology and hematology content fast. Browse Project Oncology episodes, jump into CME/CE activities, review expert perspectives, or explore timely updates on evolving treatment strategies and standards of care. New content is added regularly, so you can stay current with emerging evidence, guideline updates, and multidisciplinary approaches to cancer care on your schedule.

Start with the latest programs below or browse by content type to find the Oncology and Hematology education most relevant to your practice.

1011

LikeLikedUnlike

136-150 of 355

Spotlight on Latin America: Closing the Gap
MinuteCE®
Spotlight on Latin America: Closing the Gap
- Cynthia Villarreal-Garza, MD, DSc
1.00 program credits
MinuteCE®
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
- Kathleen N. Moore, MD
- Joyce F. Liu, MD, MPH
0.50 credits 5 episodes
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
- Joyce F. Liu, MD, MPH
0.50 program credits
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
MinuteCE®
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
- Joyce F. Liu, MD, MPH
0.50 program credits
MOA: CDH6-Targeted Antibody-Drug Conjugates
MinuteCE®
MOA: CDH6-Targeted Antibody-Drug Conjugates
- Kathleen N. Moore, MD
0.50 program credits
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
MinuteCE®
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
- Kathleen N. Moore, MD
0.50 program credits
advertisement
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
MinuteCE®
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms
- Joyce F. Liu, MD, MPH
- Kathleen N. Moore, MD
0.50 program credits
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
CME/CE
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment
- Joshua Richter, MD
1.00 credits
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
MinuteCE®
Guideline Recommendations in First-Line Treatment of HER2-Negative Upper GI Cancers
- James M. Cleary, MD, PhD
0.50 program credits
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
MinuteCE®
Distinguishing First-Line Treatment Adverse Event Profiles in HER2-Negative Upper GI Cancers
- James M. Cleary, MD, PhD
0.50 program credits
MinuteCE®
Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making  
- James M. Cleary, MD, PhD
0.50 credits 4 episodes
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
MinuteCE®
Quick Case: Strategizing Treatment Selection in HER2-/PD-L1+ Gastric Cancer
- James M. Cleary, MD, PhD
0.50 program credits
advertisement
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
MinuteCE®
Pivotal Data in Anti-PD-1 Strategies for HER2-Negative Upper GI Cancers  
- James M. Cleary, MD, PhD
0.50 program credits
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From ESMO 2025
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits
MinuteCE®
Transformative Insights: Latest Evidence for B7-H3 ADCs From WCLC and ESMO 2025  
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 credits 6 episodes